Interleukin 12 and innate molecules for enhanced mucosal immunity

Immunologic Research

Volumn 20, Issue 2, 1999, Pages 207-217

  Boyaka, Prosper N ^a   Lillard Jr , James W ^a,b   McGhee, Jerry ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant; Defensins; Interleukin 12; Interleukin 6; Lymphotactin; Mucosal immunity; Secretory IgA; T helper; Vaccines

Indexed keywords

ANTIBODY; ANTIGEN; CYTOKINE; DEFENSIN; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 12; INTERLEUKIN 6; LYMPHOTACTIN; PEPTIDE; SECRETORY IMMUNOGLOBULIN; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; HELPER CELL; IMMUNE RESPONSE; IMMUNITY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH2 CELL;

EID: 0033499877     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02790404     Document Type: Review

References (68)

1. 1 Vajdy M, Kosco-Vilbois MH, Kopf M, Kohler G, Lycke N: Impaired mucosal immune response in interleukin 4-targeted mice. J Exp Med 1995;181:41-53.
2. 2 Marinaro M, Staats HF, Hiroi T, Jackson RJ, Coste M, Boyaka PN, Okahashi N, Yamamoto M, Bluethmann H, Fujihashi K, Kiyono H, McGhee JR: Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. Immunol 1995;155:4621-4629.
3. 3 Okahashi N, Yamamoto M, Vancott JL, Chatfield SN, Roberts M, Bluethmann H, Hiroi T, Kiyono H, McGhee JR: Oral immunization of interleukin-4(IL-4) knockout mice with a recombinant Salmonella starin or cholera toxin reveals that CD4+ Th2 cells producing 1L-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect Immun 1996;64:1516-1525.
4. 4 VanCott JL, Staats HF, Pascual DW, Roberts M, Chatfield SN, Yamamoto M, Coste M, Carter PB, Kiyono H, McGhee JR: Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol 1996;156:1504-1514.
5. + cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sc (USA) 1993;90:1 0188-10192.
6. 6 Mosmann TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
7. 7 Finkelman FD, Holmes J, Katona IM, Urban Jr. JF, Beckmann MP, Parks LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE: Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990;8:303-333.
8. 8 Seder RA, Paul WE: Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994;12:635-673.
9. 9 Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170:827-845.
10. 10 Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor (interleukin 12[IL-12])inducesThelper type 1 (Th1)-specific immune responses and inhibits the developmentof IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
11. 11 Trinchieri G: Interleukin-12: a pro-inflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.
12. 12 Luger TA, Krutmann J, Kirnbauer R, Urbanski A, Schwarz T, Klappacher G, Kock A, Micksche M, Malejczyk J, Schauer E: IFN-beta 2/IL-6 augments the activity of human natural killer cells. J Immunol 1989;143:1206-1209.
13. + precursor subpopulations. J Immunol 1993;151:2895-2903.
14. + T cells. J Exp Med 1997;185:461-469.
15. 15 Kishimoto T: The biology of interleukin-6. Blood 1989;74:1-10.
16. 16 Vogel LA, Showe LC, Lester TL, McNutt RM, Van Cleave VH, Metzger DW: Direct binding of IL-12 to human and murine B lymphocytes. Intern Immunol 1996; 8:1955-1962.
17. 17 Metzger DW, McNutt RM, Collins JT, Buchanan IM, Van Cleave VH, Dunnick WA: Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms. Eur J Immunol 1997; 27:1958-1965.
18. 18 Li L, Young D, Wolf SF, Choi YS: Interleukin-12 stimulates B cell growth by inducing IFN-gamma. Cell Immunol 1996;168:133-140.
19. 19 Beagley KW, Eldridge JH, Lee F, Kiyono H, Everson MP, Koopman WJ, Hirano T, Kishimoto T, McGhee JR: Interleukins and IgA synthesis. Human and murine interleukin-6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med 1989;169:2133-2148.
20. 20 Bromander AK, Ekman L, Kopf M, Nedrud JG, Lycke NY: IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection. J Immunol 1996; 156:4290-4297.
21. 21 Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, Kopf M: The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994;264:561-563.
22. 22 Selsted ME, Szklarek D, Lehrer RI: Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun 1984;45:150-154.
23. 23 Fleischmann J, Church JA, Lehrer RI. Primary Candida meningitis and chronic granulomatous disease. Am J Med Sci 1986;291: 334-341.
24. 24 Porter EM, Van Dam E, Valore EV, Ganz T: Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun 1997;65:2396-2401.
25. 25 Porter EM, Liu L, Oren A, Anton PA, Ganz T: Localization of human intestinal defensin 5 in paneth cell granules. Infect Immun 1997; 65:2389-2395.
26. 26 Harwig SS, Park AS, Lehrer RI: Characterization of defensin precursors in mature human neutrophils. Blood 1992;79:1532-1537.
27. 27 Jones DE, Bevins CL: Paneth cells of the human small intestine express in antimicrobialmpeptide gene. J Bio Chem 1992;267: 23216-23225.
28. 28 Stolzenberg ED, Anderson GM, Ackermann MR, Whitlock RH, Zasloff M: Epithelial antibiotic induced in states of diseased. Proc Natl Acad Sci (USA) 1997;94:8686-8690.
29. 29 Murphy CJ, Foster BA, Mannis MJ, Selsted ME, Reid TW: Defensive are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 1993;155: 408-413.
30. 30 Eisenhauer PB, Harwig SS, Lehrer RI. Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun 1992;60:3556-3565.
31. 31 Huttner KM, Selsted ME, Ouellette AJ: Structure and diversity of the murine cryptdin gene family. Genomics 1994;19:448-453.
32. 32 Chertov O, Michiel DF, Xu L, Wang JM,Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ: Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Bio Chem 1996;271: 2935-2940.
33. 33 Boismenu R, Feng L, Xia YY, Chang JC, Harvan WL: Chemokine expression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia. J Immunol 1996; 157:985-992.
34. 34 Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, Zlotnik A: Lymphotactin: a cytokine that represents a new class of chemokine. Science 1994;266:1395-1399.
35. 35 Kennedy J, Kelner GS, Kleyensteuber S, Schall TJ, Weiss MC, Yssl H, Schneider PV, Cocks BG, Bacon KB, Zlotnik A: Molecular cloning and functional characterization of human lymphoactin. J Immunol 1995;155:203-209.
36. 36 Sozzani S, Luini W, Borsatti A, Polentarutti N, Zhou D, Piemonti L, D'Amico G, Power CA, Wells TN, Gobbi M, Allavena P, Mantovani A: Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 1997;159:1993-2000.
37. 37 Giancarlo B, Silvano S, Albert Z, Mantovani A, Allavena P: Migratory response of human natural killer cells to lymphotactin. Eur J Immunol 1996;26:3238-3241.
38. 38 Borthwick NJ, Akbar AN, MacCormac LP, Lowdell M, Craigen JL, Hassan I, Grundy JE, Salmon M, Yong KL: Selective migration of highly differentiated primed T cells, defined by low expression of CD45RB, across human umbilical vein endothelial cells: effects of viral infection on transmigration. Immunol 1997;90:272-280.
39. 39 McGhee JR, Lamm ME, Strober W: Mucosal immune responses: An overview: in Orga PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR (eds): Mucosal Immunology. Academic press, 1999, pp 485-506.
40. 40 Rollwagen FM, Baqar S: Oral cytokine administration. Immunol Today 1996;17:548-550.
41. 41 Marinaro M, Boyaka PN, Finkelman FD, Kiyono H, Jackson RJ, Jirillo E, McGhee JR: Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med 1997;185:415-427.
42. 42 Marinaro M, Boyaka PN, Jackson RJ, Finkelman FD, Kiyono H, Jirillo E, McGhee JR: Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin. J Immunol 1999; 162:114-121.
43. 43 Boyaka PN, Marinaro M, Jackson RJ, Menon S, Kiyono H, Jirillo E, McGhee JR: IL-12 is an effective adjuvant for induction of mucosal immunity. J Immunol 1999; 162:122-128.
44. 44 Elson CO, Dertzbaugh MT: 1999. Mucosal adjuvants, in Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR (eds): Mucosal Immunology. Academic press, 1999, pp 817-838.
45. 45 Baqar S, Pacheco ND, Rollwagen FM: Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines. Antimicrob Agents Chemother 1993;37:2688-2692.
46. 46 Okada E, Sasaki S, Ishii N, Aoki I, Yasuda T, Nishioka K, Fukushima J, Miyazaki J, Wahren B, Okuda K: Intranasal immunization of a DNA vaccine with IL-12-and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol 1997;159: 3638-36547.
47. 47 Arulanandam BP, Metzger DW: Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery. Vaccine 1999; 17:252-260.
48. 48 Takahashi I, Marinaro M, Kiyono H, Jackson RJ, Nakagawa I, Fujihashi K, Hamada S, Clements JD, Bost KL, McGhee JR: Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis 1996;173: 627-635.
49. 49 Levine MM, Kaper JB, Black RE, Clements ML: New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiological Reviews 1983;47:510-550.
50. 50 Douce G, Turcotte C, Cropley I, Roberts M, Pizza M, Domenghini M, Rappuoli R, Dougan G: Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci (USA) 1995;92:1644-1648.
51. 51 Yamamoto S, Kiyono H, Yamamoto M, Imaoka F, Fujihashi K, Van Ginkel FW, Noda M, Takeda Y, McGhee JR: A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci (USA) 1997;94:5267-5272.
52. 52 Germann T, Guckes S, Bongartz. M, Dlugonska H, Schmitt E, Kolbe L, Kolsch E, Podlaski FJ, Gately MK, Rude E: Adminstration of IL-12 during ongoing immune responses fails to permanently suppress and can even enhance the synthesis of antigen-specific IgE. Intern Immunol 1995;7:1649-1657.
53. 53 Wynn TA, Jankovic D, Hieny S, Zioncheck K, Jardieu P, Cheever AW, Sher A: IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-gamma. J Immunol 1995;154:3999-4009.
54. 54 Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI: Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985;76: 1427-1435.
55. 55 Ogata K, Linzer BA, Zuberi RI, Ganz T, Lehrer RI, Catanzaro A: Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare. Infect Immun 1992;60:4720-4725.
56. 56 Lillard Jr. WJ, Boyaka PN, Chertov O, Oppenheim JJ, McGhee JR: Mechanism for induction of acquired host immunity by neutrophil peptide defensins. Proc Natl Acad Sci (USA) 1999;96:651-656.
57. - T cells for helper activity. Intern Immunol 1993;5:1473-1481.
58. 58 Kawabata S, Boyaka PN, Coste M, Fujihashi K, Yamamoto M, McGhee JR, Kiyono H: Intraepithelial lymphocytes from villus tip and crypt portions of the murine small intestine show distinct characteristics. Gastroenterology 1998;115:866-873.
59. 59 Barrett TA, Gajewski TF, Danielpour D, Chang EB, Beagley KW, Bluestone JA: Differential function of intestinal intraepithelial lymphocyte subsets. J Immunol 1992;149:1124-1130.
60. + T cells produce IFN-gamma and IL-5. J Immunol 1991;147:3736-3744.
61. 61 Hedrick JA, Saylor V, Figueroa D, Mizoue L, Xu Y, Menon S, Abrams J, Handel T, Zlotnik A: Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J Immunol 1997;158:1533-1540.
62. 62 Dilloo D, Bacon K Holden W, Zhong W, Burdach S, Zlotnik A, Brenner M: Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nature Med 1996;2:1090-1095.
63. 63 Lillard Jr. JW, Boyaka PN, Hedrick JA, Zlotnik A, McGhee JR: Lymphotactin acts as an innate mucosal adjuvant. J Immunol 1999; 162: 1959-1965.
64. 64 Fujihashi K, McGhee JR, Kweon MN, Cooper MD, Tonegawa S, Takahashi I, Hiroi T, Mestecky J, Kiyono H: Gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses. J Exp Med 1996;183: 1929-1935.
65. 65 Komano H, Fujiura Y, Kawaguchi M, Matsumoto S, Hashimoto Y, Obana S, Mombaerts P, Tonegawa S, Yamamoto H, Itohara S, Nanno M, Ishikawa H: Homeostatic regulation of intestinal epithelial by intraepithelial gamma delta T cells. Proc Natl Acad Sci (USA) 1995;92:6147-6151.
66. 66 van Ginkel FW, McGhee JR, Liu C, Simecka JW, Yamamoto M, Frizzell RA, Sorscher EJ, Kiyono H, Pascual DW: Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene. J Immunol 1997;159: 685-693.
67. 67 Cong Y, Weaver CT, Elson CO. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective ,up-regulation of B7.2 expression. J Immunol 1997;159: 5301-5308.
68. 68 VanCott JL, Chatfield SN, Roberts M, Hone DM, Hohmann EL, Pascual DW, Yamamoto M, Kiyono H, McGhee JR: Regulation of host immune responses by modification of Salmonella virulence genes. Nature Med 1998;4:1247-1252.